Similarly,
European union opens way new:
The European Medicines Agency (EMA) gave its green light on Friday for the Lenacapavir. For example, which would reduce the risk of infection with the AIDS virus.
A new step forward in the fight against HIV. Consequently, The European Medicines Agency (EMA) recommended on Friday the authorization of a new ultra-prometting treatment against HIV. Similarly, called Yeytuo (Lenacapavir molecule), which scientists feel likely to contribute to ending the transmission of the virus.
In a press release. Similarly, the European regulator judges european union opens way new that its LenacapAvir assessments, marketed under the name of Yeytuo in Europe by Gilead Sciences, show that this drug is “Very effective” et “A major interest in public health”. If preventive treatments exist. such as condoms or cabotégravir, administered every two months, the Lenacapavir offers six -month protection, making it the most sustainable option. This injectable medication reduces the risk of infection.
Pass advertising
Already authorized in the United States – European union opens way new
Authorized since mid-June by the American Agency for Medicines (FDA) in the United States. the authorization of Lenacapavir must now be validated by the European Commission, a formality, then the use of treatment will be valid in the 27 Member States, as well as in Iceland, Norway and Liechtenstein. On the other hand. in France, the High Authority for Health must still give the green light before it is available.
In the event of a positive european union opens way new response. the authorities and the laboratory will have to agree on a tariff for a drug whose injection costs $ 30,000 a year to the United States. Last year. studies suggested that Lenacapavir, already used to treat people living with HIV, was effective at almost 100 % to prevent transmission in women and men.
Winnie Byanyima. Executive Director of the United Nations Agency against AIDS (UNAIDS), said this medication “Could change the course of the HIV epidemic” If it was made accessible to all the people who need it. In July. the World Health Organization (WHO) recommended that countries offer this medication as an additional option for people exposed to the virus. Last year. around 630,000 people died of AIDS worldwide, and more than 40 million people would live with HIV, according to UNAIDS data.
Further reading: Interview with the Governor of Maine | Close ties to preserve – 5G in Europe and Switzerland: a halftime assessment – The Bordeaux vineyard has torn 18 % of its surface in two years and “it would be necessary to tear even more” – “Billions for an uncertain future”: China reveals a colossal center dedicated to nuclear fusion, shock revelations thanks to these secret satellite images – In the Gers, a wine intenut center to adapt to the market.